CDNA R&D to Revenue
Caredx Inc · R&D to Revenue
CDNA R&D to Revenue
Latest reported18.81%period ending
CDNA FY R&D/Revenue (23.24% → 18.81%)
Latest values, visible window
High-resolution chart · PNG
CDNA r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 18.8068% | |
| 21.6921% | |
| 29.2041% | |
| 28.0889% | |
| 25.8184% | |
| 25.4644% | |
| 24.1689% | |
| 18.9555% | |
| 25.6353% | |
| 30.4817% | |
| 33.1616% | |
| 14.0848% | |
| 14.3723% | |
| 23.236% |